Cargando…
Selective targeting of neuroblastoma tumour-initiating cells by compounds identified in stem cell-based small molecule screens
Neuroblastoma (NB) is the most deadly extra-cranial solid tumour in children necessitating an urgent need for effective and less toxic treatments. One reason for the lack of efficacious treatments may be the inability of existing drugs to target the tumour-initiating or cancer stem cell population r...
Autores principales: | Smith, Kristen M, Datti, Alessandro, Fujitani, Mayumi, Grinshtein, Natalie, Zhang, Libo, Morozova, Olena, Blakely, Kim M, Rotenberg, Susan A, Hansford, Loen M, Miller, Freda D, Yeger, Herman, Irwin, Meredith S, Moffat, Jason, Marra, Marco A, Baruchel, Sylvain, Wrana, Jeffrey L, Kaplan, David R |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
WILEY-VCH Verlag
2010
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3377336/ https://www.ncbi.nlm.nih.gov/pubmed/20721990 http://dx.doi.org/10.1002/emmm.201000093 |
Ejemplares similares
-
Hypoxia-Targeting Drug Evofosfamide (TH-302) Enhances Sunitinib Activity in Neuroblastoma Xenograft Models()
por: Kumar, Sushil, et al.
Publicado: (2018) -
Acetazolamide potentiates the anti-tumor potential of HDACi, MS-275, in neuroblastoma
por: Bayat Mokhtari, Reza, et al.
Publicado: (2017) -
Oral Metronomic Topotecan Sensitizes Crizotinib Antitumor Activity in ALK(F1174L) Drug-Resistant Neuroblastoma Preclinical Models()
por: Zhang, Libo, et al.
Publicado: (2017) -
A systematic approach to identify novel cancer drug targets using machine learning, inhibitor design and high-throughput screening
por: Jeon, Jouhyun, et al.
Publicado: (2014) -
Spy'ing on differentiation in neuroblastoma
por: Podkowa, Monika, et al.
Publicado: (2014)